Effect of Pueraria tuberosa DC. (Indian Kudzu) on blood pressure, fibrinolysis and oxidative stress in patients with stage 1 hypertension

Pakistan Journal of Biological Sciences

Volumn 15, Issue 15, 2012, Pages 742-747

  Verma, S K ^a   Jain, Vartika ^b   Singh, D P ^a  

^a RNT MEDICAL COLLEGE   (India)

^b M L SUKHADIA UNIVERSITY   (India)

Author keywords

Antioxidant; Fibrinogen; Isoflavones; Puerarin; Vidarikand

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ISOFLAVONE DERIVATIVE; PLANT EXTRACT;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; BLOOD PRESSURE; CHEMISTRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FIBRINOLYSIS; HUMAN; HYPERTENSION; MIDDLE AGED; OXIDATIVE STRESS; PUERARIA; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD COAGULATION; BLOOD PRESSURE; FIBRINOLYSIS; HUMANS; HYPERTENSION; ISOFLAVONES; MIDDLE AGED; OXIDATIVE STRESS; PLANT EXTRACTS; PUERARIA; SINGLE-BLIND METHOD;

PUERARIA; PUERARIA MONTANA VAR. LOBATA; PUERARIA TUBEROSA;

EID: 84873842710     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2012.742.747     Document Type: Article

References (36)

1. Bhutani, S.P., S.S. Chibber and T.R. Seshadri, 1969. Components of the roots of Pueraria tuberosa: Isolation of a new isoflavone-c-glycoside (di-o-acetylpuerarin). Indian J. Chem., 7: 210-212.
2. Buckell, M., 1958. The effect of citrate on euglobulin methods of estimation of fibrinolytic activity. J. Clin. Pathol., 11: 403-405.
3. Burta, O., F. Tirlea, O.L. Burta and S.M. Qadri, 2008. Phytotherapy in cardiovascular diseases: From ethnomedicine to evidence based medicine. J. Biol. Sci., 8: 242-247.
4. Cai, R.L., M. Li, S.H. Xie, Y. Song, Z.M. Zou, C.Y. Zhu and Y. Qi, 2011. Antihypertensive effect of total flavone extracts from Puerariae Radix. J. Ethnopharmacol., 133: 177-183.
5. Cho, T.M., N. Peng, J.T. Clark, L. Novak, S. Roysommuti, J. Prasain and J.M. Wyss, 2007. Genistein attenuates the hypertensive effects of dietary NaCl in hypertensive male rats. Endocrinology, 148: 5396-5402.
6. Chobaman, A.V., G.L. Bakns, H.R. Black, W.C. Cushman and L.A. Green et al, 2003. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: The JNC 7 report. J. Am. Med. Assoc, 289: 2560-2571.
7. Collins, R. and S. MacMohan, 1994. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br. Med. Bull., 50: 272-278.
8. Deng, Y., E.S. Ng, J.H. Yeung, Y.W. Kwan and C.B. Lau et al., 2012. Mechanisms of the cerebral vasodilator actions of isoflavonoids of Gegen on rat isolated basilar artery. J. Ethnopharmacol., 139: 294-304.
9. Dey, A. and J.N. De, 2010. Rauvolfia serpentina (L.). Benth. ex Kurz.-A review. Asian J. Plant Sci., 9: 285-298.
10. Dong, K., Q.M. Tao, Q. Xia, Q.X. Shan and G.B. Pan, 2004. Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta. Zhongguo Zhong Yao ZaZhi, 29: 981-984.
11. Fearnley, W.B., 1963. Blood fibrinolytic activity in diabetes mellitus and its bearing on ischemic heart disease and obesity. Br. Med. J., 1: 921-923.
12. Foti, P., D. Erba, P. Riso, A. Spadafrance, Criscuoli and G. Testolin, 2005. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch. Biochem. Biophys., 433: 421-427.
13. Gao, Q., B. Yang, Z.G. Ye, J. Wang, I.C. Bruce and Q. Xia, 2007. Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin. Eur. J. Pharmacol, 574: 179-184.
14. Gupta, K.K., 1969. Cholesterol, platelet adhesiveness and fibrinolytic activity in ischemic heart disease. J. Assoc. Physc. India, 17: 323-326.
15. Guyton, A.C. and J.E. Hall, 2006. Haemostasis and Blood Coagulation. In: Textbook of Medical Physiology, Guyton, A.C. andJ.E. Hall (Eds.). 11th Edn. Saunders, Philadelphia, PA., USA., ISBN: 0721602401, pp: 464.
16. Jain, S.K., 1991. Dictionary of Indian Folk Medicine and Ethnobotany. Deep Publications, New Delhi.
17. Jam, V., S.K. Verma and S.S. Katewa, 2012. Effect of Bombax ceiba root on some cardiovascular risk parameters in patients with ischemic heart disease. Asian J.Biol. Sci., 5: 351-357.
18. Kannel, W.B., P.A. Wolf, W.P. Castelli and R.B. D'Agostino, 1987. Fibrinogen and risk of cardiovascular disease: The Framingham study. J. Am. Med. Assoc, 258: 1183-1186.
19. Kashyap, M.K., V. Yadav, B.S. Sherawat, S. Jain and S. Kumari et al., 2005. Different antioxidants status, total antioxidant power and free radicals in essential hypertension. Mol. Cell Biochem., 277: 89-99.
20. Kusano, C. and B. Ferrari, 2008. Total antioxidant capacity: A biomarker in biomedical and nutritional studies. J. Cell Mol. Biol., 7: 1-15.
21. Liu, Q., L. Wang, Z. Lu, S. Li and Y. Xiong, 1999. Effect of puerarin on coronary collateral circulation in dogs with experimental acute myocardial infarction. Zhongguo Zhong Yao Za Zhi, 24: 304-306.
22. Miller, N.J., C. Rice-Evans, M.J. Davies, V. Gopinathan and A. Milner, 1993. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci., 84: 407-412.
23. NISCAIR, 2003. The Wealth of India: J-Q. Vol. 4, National Institute of Science Communication, Council of Scientific and Industrial Research, New Delhi, India, ISBN-13: 9788172362461 Pages: 476.
24. Nath, R.L. and B. Debnath, 1970. Determination of plasma fibrinogen in human subjects. J. Indian Med. Assoc, 54: 93-95.
25. Pandey, N. and Y.B. Tripathi, 2010. Antioxidant activity of tuberosin isolated from Pueraria tuberose Linn. J. Inflamm., Vol. 14. 10.1186/1476-9255-7-47
26. Pandey, N, J.K. Chaurasia, O.P. Tiwari and Y.B. Tripathi, 2007. Antioxidant properties of different fractions of tubers from Pueraria tuberosa Linn. Food Chem., 105: 219-222.
27. Raghuwanshi, R. and B. Jain, 2012. Hypoglycemic effect of Pueraria tuberosa tubers in healthy and alloxan diabetic rats. J. Chem. Biol. Phys. Sci., 2: 270-272.
28. Ram, M., K. Nath, T.N. Mehrotra and S.D. Mishra, 1981. Fibrinolytic activity in coronary artery disease. J. Postgraduate Med., 27: 105-108.
29. Ratnam, K.V. and R.R.V. Raju, 2009. Preliminary phytochemical and antimicrobial properties of Pueraria tuberosa (Willd.) DC: A potential medicinal plant. Ethnobot Leaflets, 13: 1051-1059.
30. Sun, X.H., J.P. Ding, H. Li, N. Pan, L. Gan, X.L. Yang and H.B. Xu, 2007. Activation of large-conductance calcium-activated potassium channels by puerarin: The underlying mechanism of puerarin-mediated vasodilation. J. Pharmacol. Exp. Ther., 323: 391-397.
31. Tanwar, Y., S. Goyal and K. Ramawat, 2008. Hypolipidemic effects of tubers of Indian kudzu (Pueraria tuberosa). J. Herb. Med. Toxicol., 2: 21-25.
32. Vera, R., M. Sanchez, M. Galisteo, I.C. Villar and R. Jimenez et al, 2007. Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: Involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin. Sci., 12: 183-191.
33. Verma, S.K., V. Jain and A. Vyas, 2009a. Fibrinolysis enhancement by Pueraria tuberosa (Indian Kudzu) in patients with coronary artery disease: A placebo controlled study. J. Cell Tissue Res. 9: 1649-1654.
34. Verma, S.K., V. Jain, A. Vyas and D.P. Singh, 2009b. Protection against stress induced myocardial ischemia by Indian Kudzu (Pueraria tuberosa): A case study. J. Herbal Med. Toxicol., 3: 59-63.
35. Warner, P.K, P. K. Nambiar and P.S. Warner, 1997. Indian Medicinal Plants: A Compendium of 500 Species. Vol. 4, Orient Longman Publishing, Kottakkal, Kerala, India.
36. Wong, K.H., G.Q. Li, K.M. Li, V. Razmovski-Naumovski and K. Chan, 2011. Kudzu root: Traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J. Ethnopharmacol., 134: 584-607.